U.S. flag

An official website of the United States government

GTR Home > Laboratories > Diagnosticum Center for Human Genetics

Diagnosticum Center for Human Genetics

GTR Lab ID: 319933, Last updated:2021-04-28
Annual Review past due read more


Conditions and tests

  • Alcohol dependence1 test
  • Alcohol sensitivity, acute1 test
  • Amitriptyline response1 test
  • Anemia, nonspherocytic hemolytic, due to G6PD deficiency1 test
  • Angiotensin i-converting enzyme, benign serum increase1 test
  • Beta-2-adrenoreceptor agonist, reduced response to1 test
  • Capecitabine response1 test
  • Catechol-o-methyltransferase deficiency1 test
  • Citalopram response1 test
  • Clopidogrel response2 tests
  • Codeine response1 test
  • Colchicine resistance1 test
  • CYP2C19-related poor drug metabolism2 tests
  • Deficiency of butyrylcholinesterase1 test
  • Dihydropyrimidine dehydrogenase deficiency2 tests
  • Disorder due cytochrome p450 CYP1A21 test
  • Disorder due cytochrome p450 CYP2C19 variant1 test
  • Disorder due cytochrome p450 CYP2C9 variant1 test
  • Disorder due cytochrome p450 CYP2D6 variant2 tests
  • Doxepin response1 test
  • Efavirenz response1 test
  • Escitalopram response1 test
  • Esomeprazole response1 test
  • Essential hypertension1 test
  • Fluoropyrimidine response1 test
  • Fluorouracil response1 test
  • Fluvoxamine response1 test
  • Glycogen storage disease1 test
  • Hepatitis C virus, susceptibility to1 test
  • Hereditary thrombophilia1 test
  • Homocystinuria due to methylene tetrahydrofolate reductase deficiency2 tests
  • Homocystinuria due to MTHFR deficiency1 test
  • Inherited susceptibility to asthma1 test
  • Irinotecan response1 test
  • Malaria, susceptibility to1 test
  • Mercaptopurine response1 test
  • Microvascular complications of diabetes, susceptibility to, 51 test
  • Microvascular complications of diabetes, susceptibility to, 61 test
  • Nortriptyline response1 test
  • Obesity1 test
  • Paroxetine response1 test
  • Pseudocholinesterase deficiency1 test
  • Selective serotonin reuptake inhibitor response1 test
  • Sertraline response1 test
  • Simvastatin response1 test
  • Slow acetylator due to N-acetyltransferase enzyme variant2 tests
  • Statin-induced myopathy1 test
  • Tacrolimus response1 test
  • Tamoxifen response1 test
  • Tegafur response1 test
  • Thioguanine response1 test
  • Thiopurine methyltransferase deficiency1 test
  • Thrombophilia due to activated protein C resistance1 test
  • Thrombophilia due to thrombin defect2 tests
  • Tobacco addiction, susceptibility to1 test
  • Ubiquitous Glucose-6-Phosphatase Deficiency1 test
  • Vitamin K-dependent clotting factors, combined deficiency of, type 21 test
  • Warfarin response1 test

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Confirmation of research findings
  • Custom Balanced Chromosome Rearrangement Studies
  • Custom Deletion/Duplication Testing
  • Prenatal testing
  • Custom Sequence Analysis
  • Custom microarray analysis
  • Carrier testing
  • Genetic counseling
  • Marker Chromosome Identification
  • Maternal cell contamination study (MCC)
  • Mutation Confirmation
  • Result interpretation
  • Uniparental Disomy (UPD) Testing
  • Whole Exome Sequencing
  • Clinical exome, comments

List of certifications/licenses


  • CAP, Number: 7234132, Expiration date: 2013-01-17
  • CAP, Number: 7234132, Expiration date: 2015-01-17
  • CAP, Number: 7234132, Expiration date: 2017-01-17
  • CAP, Number: 7234132, Expiration date: 2019-01-17
  • CAP, Number: 7234132, Expiration date: 2021-01-17

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.